cheynew, I would add to that:
...and the aftermath of the 2012/Q1 1st ln NSCLC results that also had an outperforming control arm.
And yes, you are correct. I anticipated a wash-out before big new, there always is.
BUT...I'll be honest and open about this I NEVER would have expected it to happen with a FAILED SUNRISE trial!
Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.